Government News

Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis: EMA

  • Posted on: 25 March 2019
  • By: Shalini.Sharma

EMA is advising healthcare professionals and patients not to exceed the recommended dose of Xeljanz (tofacitinib) when treating rheumatoid arthritis. The advice follows early results from an ongoing study (study A3921133) in patients with rheumatoid arthritis which showed an increased risk of blood clots in the lungs and death when the normal dose of 5 mg twice daily was doubled.

Health Ministry takes stock of the public health measures for controlling West Nile Virus

  • Posted on: 15 March 2019
  • By: Shalini.Sharma

A section of the media has reported that a seven year old boy from Malappuram District of Kerala is suffering from a West Nile Virus (WNV), a mosquito-borne disease, mostly reported in the continental United States. Union Minister of Health and Family Welfare is closely monitoring the situation and has spoken to the State Health Minister of Kerala in this regard. He has directed for all support to be extended to Kerala in its prevention and management.

Significant Reduction in Cancer Drug Prices due to Trade Margin Capping

  • Posted on: 1 March 2019
  • By: Shalini.Sharma

Cancer is one of the leading causes of adult illness and death due to chronic non-communicable diseases in India.   India is witnessing a steady rise in cancer incidence.  The number of incident-cases has risen from 8 lakh in 2004 to an estimated 15 lakh (annually) by 2018.  Even with nearly two third of patients eventually dying of this disease, an estimated 22.5 lakh patients are currently living with cancer in India.

Countries are spending more on health, but people are still paying too much out of their own pockets : WHO

  • Posted on: 22 February 2019
  • By: Shalini.Sharma

Health spending is made up of government expenditure, out-of-pocket payments (people paying for their own care), and sources such as voluntary health insurance, employer-provided health programmes, and activities by non-governmental organizations.

Ministry of AYUSH introduced new Central Sector scheme for promoting Pharmacovigilance of AYUSH Drugs

  • Posted on: 20 February 2019
  • By: Shalini.Sharma

Ministry of AYUSH has introduced new Central Sector scheme for promoting pharmacovigilance of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) Drugs. Prime objective of the scheme is to develop the culture of documenting adverse effects and undertake safety monitoring of Ayurveda, Siddha, Unani and Homoeopathy drugs and surveillance of misleading advertisements appearing in the print and electronic media. The Standing Finance Committee (SFC) chaired by Secretary (AYUSH) approved the scheme on 1st November, 2017 and thereafter it was rolled out for implementation in the country near the end of financial year 2017-18.

12500 health and wellness centres need to be identified across the country for rendering AYUSH services: Shri Shripad Naik

  • Posted on: 8 February 2019
  • By: Shalini.Sharma

The fourth Conference of AYUSH/Health Ministers of States/UTs was inaugurated by the Minister of State for AYUSH (Independent Charge) Shri Shripad Yesso Naik in New Delhi today. The day long conference was organized by the Ministry of AYUSH to provide an opportunity to States/UT to interact with each other for the development of AYUSH sector. The conference was attended by AYUSH/Health Ministers/Secretaries and officials from 29 States/UTs; senior officials of AYUSH Ministry and representatives of AYUSH organizations.

NIH study provides answer to long-held debate on blood sugar control after stroke

  • Posted on: 8 February 2019
  • By: Shalini.Sharma

Hyperglycemia, or increased glucose, is common in patients with acute ischemic stroke and is associated with worse outcomes compared to normal glucose levels. Doctors all over the world have debated whether intensive glucose management, which requires the use of IV insulin to bring blood sugar levels down to 80-130 mg/dL, or standard glucose control using insulin shots, which aims to get glucose below 180 mg/dL, lead to better outcomes after stroke. Primary results from the Stroke Hyperglycemia Insulin Network Effort (SHINE) study, a large, multisite clinical study provide a clear answer to that question.